Gossamer Bio (GOSS) Market Capitalization (2019 - 2026)

Gossamer Bio has reported Market Capitalization for 8 years, with the latest figure at $51.2 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 81.69% year-over-year to $51.2 million in Q2 2026; TTM through Jun 2026 was $51.2 million, a 81.69% decrease from a year earlier, with the FY2025 full-year figure at $724.4 million, up 255.2% from the prior year.
• Market Capitalization was $51.2 million for Q2 2026 at Gossamer Bio, down from $77.4 million in the prior quarter.
• The five-year high for Market Capitalization was $1.1 billion in Q3 2022, with the low at $51.2 million in Q2 2026.
• Average Market Capitalization over 5 years is $338.2 million, with a median of $214.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization sank 83.37% in 2023, then surged 255.2% in 2025.
• Over 5 years, Market Capitalization stood at $204.9 million in 2022, then tumbled by 32.22% to $138.9 million in 2023, then jumped by 46.84% to $203.9 million in 2024, then soared by 255.2% to $724.4 million in 2025, then slumped by 92.93% to $51.2 million in 2026.
• The last three Market Capitalization figures came in at $51.2 million (Q2 2026), $77.4 million (Q1 2026), and $724.4 million (Q4 2025), per Business Quant data.